Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary.
Department of Anesthesiology and General Intensive Care Medicine, Medical University of Vienna, Vienna, Austria.
PLoS One. 2018 Jun 28;13(6):e0196188. doi: 10.1371/journal.pone.0196188. eCollection 2018.
Fluid resuscitation is the cornerstone of treatment in hemorrhagic shock. Despite increasing doubts, several guidelines recommend to maintain mean arterial pressure (MAP) >65 mmHg as the most frequent indication of fluid therapy. Our aim was to investigate the effects of a MAP-guided management in a bleeding-resuscitation animal experiment.
After anesthesia and instrumentation (tbsl) animals were bled till the initial stroke volume index dropped by 50% (t0). Fluid replacement was performed in 4 equivalent steps (t1-4) with balanced crystalloid solution to reach the baseline values of MAP. Invasive hemodynamic measurements and blood gas analyses were performed after each step.
Mean arterial pressure dropped from tbsl to t0 (114±11 vs 76.9±16.9 mmHg, p<0.001) and returned to baseline by t4 (101.4±14.4 mmHg). From tbsl-t0 stroke volume index (SVI), cardiac index (CI) decreased (SVI: 40±8.6 vs 19.3±3.6 ml/m2, p<0.001; CI: 3.4±0.3 vs 1.9±0.3 l/min/m2, p<0.001), pulse pressure variation (PPV) increased (13.2±4.3 vs 22.1±4.3%, p<0.001). There was a decrease in oxygen delivery (464±45 vs 246±26.9 ml/min, p<0.001), central venous oxygen saturation (82.8±5.4 vs 53.6±12.1%, p<0.001) and increase in lactate levels (1.6±0.4 vs 3.5±1.6 mmol/l, p<0.005). SVI, CI and PPV returned to their initial values by t2. To normalize MAP fluid therapy had to be continued till t4, with the total infused volume of 4.5±0.8 l.
In the current experiment bleeding led to hemorrhagic shock, while MAP remained higher than 65 mmHg. Furthermore, MAP was unable to indicate the normalization of SVI, CI and PPV that resulted in unnecessary fluid administration. Our data give further evidence that MAP may be an inappropriate parameter to follow during fluid resuscitation.
液体复苏是失血性休克治疗的基石。尽管存在越来越多的质疑,但多项指南仍建议将平均动脉压(MAP)维持在>65mmHg 作为液体治疗的最常见指征。我们的目的是在出血复苏动物实验中研究 MAP 指导管理的效果。
麻醉和仪器置入(tbsl)后,动物出血直至初始每搏量指数下降 50%(t0)。使用平衡晶体溶液进行 4 次等量的液体替代,以达到 MAP 的基线值。在每一步后进行有创血流动力学测量和血气分析。
平均动脉压从 tbsl 下降至 t0(114±11 与 76.9±16.9mmHg,p<0.001),并在 t4 时恢复至基线水平(101.4±14.4mmHg)。从 tbsl-t0 时,每搏量指数(SVI)和心指数(CI)降低(SVI:40±8.6 与 19.3±3.6ml/m2,p<0.001;CI:3.4±0.3 与 1.9±0.3l/min/m2,p<0.001),脉压变异(PPV)增加(13.2±4.3 与 22.1±4.3%,p<0.001)。氧输送(464±45 与 246±26.9ml/min,p<0.001)、中心静脉血氧饱和度(82.8±5.4 与 53.6±12.1%,p<0.001)降低,乳酸水平升高(1.6±0.4 与 3.5±1.6mmol/l,p<0.005)。SVI、CI 和 PPV 在 t2 时恢复到初始值。为了使 MAP 正常化,需要在 t4 前继续进行液体治疗,总输液量为 4.5±0.8l。
在本实验中,出血导致失血性休克,而 MAP 仍高于 65mmHg。此外,MAP 无法指示 SVI、CI 和 PPV 的正常化,导致不必要的液体输注。我们的数据进一步证明,MAP 可能是液体复苏期间不适合跟踪的参数。